SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001169245-20-000047
Filing Date
2020-04-24
Accepted
2020-04-24 17:21:32
Documents
5
Period of Report
2020-04-24
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy2020.htm DEF 14A 598772
2 phasebio2020proxystat_image1.jpg GRAPHIC 27705
3 phasebio2020proxystat_image2.gif GRAPHIC 3535
4 proxycardpage1.jpg GRAPHIC 569664
5 proxycardpage2.jpg GRAPHIC 425480
  Complete submission text file 0001169245-20-000047.txt   2002939
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38697 | Film No.: 20816172
SIC: 2834 Pharmaceutical Preparations